MedPath
HSA Approval

ROFAST 20 FILM-COATED TABLETS 20 MG

SIN15835P

ROFAST 20 FILM-COATED TABLETS 20 MG

ROFAST 20 FILM-COATED TABLETS 20 MG

October 21, 2019

APOTHECA MARKETING PTE LTD

APOTHECA MARKETING PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPOTHECA MARKETING PTE LTD
Licence HolderAPOTHECA MARKETING PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C10AA07

rosuvastatin

Manufacturer Information

APOTHECA MARKETING PTE LTD

Aurobindo Pharma Limited, Unit VII

Active Ingredients

Rosuvastatin calcium 20.790 mg eqv Rosuvastatin

20 mg

Rosuvastatin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ROFAST 20 FILM-COATED TABLETS 20 MG - HSA Approval | MedPath